Prostatic Neoplasms: all 6,484 studies

Page 21 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving AbirateroneTerminatedNCT01681433Phase 2Results posted
• GP Extended Action TriptorelinTerminatedNCT01673984Phase 4Results posted
• A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to HistopathologyCompletedNCT01667536Phase 2Results posted
• FACBC Outcomes for Post ProstatectomyCompletedNCT01666808Phase 2/3Results posted
• Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate CancerCompletedNCT01666314Phase 1/2Results posted
• Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate CancerCompletedNCT01664923Phase 2Results posted
• High-Dose Stereotactic Radiation for Prostate CancerCompletedNCT01664130Not applicableResults posted
• Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT01656304Phase 2Results posted
• Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate CancerCompletedNCT01656161Phase 3Results posted
• Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal CancerTerminatedNCT01650350Phase 2Results posted
• Cabazitaxel and Radiation For Patients With Prostate CancerTerminatedNCT01650285Phase 2Results posted
• A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer PatientsCompletedNCT01650194Phase 2Results posted
• Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate CancerTerminatedNCT01642732Phase 1Results posted
• A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate CancerCompletedNCT01637402Phase 2Results posted
• Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate CancerCompletedNCT01630590Phase 2Results posted
• A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyCompletedNCT01624220Not applicableResults posted
• Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate CancerCompletedNCT01620593Phase 2Results posted
• Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate CancerTerminatedNCT01618838Not applicableResults posted
• Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate CancerCompletedNCT01615120Phase 2Results posted
• Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen AblationCompletedNCT01607879Phase 2Results posted
• Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100CompletedNCT01605227Phase 3Results posted
• High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic NoduleCompletedNCT01605097Not applicableResults posted
• External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate CancerTerminatedNCT01603420Phase 2/3Results posted
• Protection of Rectum From High Radiation DosesCompletedNCT01601691Not applicableResults posted
• Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate CancerCompletedNCT01599793Phase 2Results posted
• Cabozantinib in Advanced Solid MalignanciesCompletedNCT01588821Phase 2Results posted
• Saw Palmetto: Symptom Management for Men During Radiation TherapyCompletedNCT01585246Phase 1/2Results posted
• Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate CancerCompletedNCT01578902Not applicableResults posted
• Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01576172Phase 2Results posted
• Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate CancerCompletedNCT01565928Phase 1Results posted
• Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerCompletedNCT01560923Phase 2Results posted
• Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate CancerTerminatedNCT01558492Phase 2Results posted
• AMG 386 and Abiraterone for Advanced Prostate CancerCompletedNCT01553188Phase 2Results posted
• Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01549951Phase 2Results posted
• Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate CancerCompletedNCT01547299Phase 2Results posted
• Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerCompletedNCT01546987Phase 3Results posted
• A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal TherapyCompletedNCT01546623Phase 3Results posted
• Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate CancerCompletedNCT01543776Phase 2Results posted
• Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerCompletedNCT01542021Not applicableResults posted
• Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerCompletedNCT01540994Not applicableResults posted
• Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate CancerCompletedNCT01540071Phase 2Results posted
• SpaceOAR System Pivotal StudyCompletedNCT01538628Phase 3Results posted
• Memantine Hydrochloride in Helping Cancer Survivors Stop SmokingCompletedNCT01535040Phase 2Results posted
• A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100CompletedNCT01534052Phase 2Results posted
• Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate CancerTerminatedNCT01533753Phase 2Results posted
• Linsitinib in Treating Patients With Asymptomatic or Mildly Symptomatic Metastatic Prostate CancerCompletedNCT01533246Phase 2Results posted
• Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSATerminatedNCT01531205Phase 2Results posted
• Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerTerminatedNCT01522443Phase 3Results posted
• Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSACompletedNCT01521949Phase 2Results posted
• Tivantinib in Treating Patients With Metastatic Prostate CancerCompletedNCT01519414Phase 2Results posted
• A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateCompletedNCT01517802Phase 3Results posted
• Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate CancerCompletedNCT01511536Phase 1/2Results posted
• Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate CancerCompletedNCT01505868Phase 1/2Results posted
• Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01503229Phase 2Results posted
• Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)TerminatedNCT01499043Phase 2Results posted
• Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01498978Phase 2Results posted
• Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate CancerCompletedNCT01496157Phase 1/2Results posted
• Tecemotide (L-BLP25) in Prostate CancerCompletedNCT01496131Phase 2Results posted
• Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate CancerCompletedNCT01487863Phase 2Results posted
• Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel ChemotherapyCompletedNCT01485861Phase 1/2Results posted
• Pre-Prostatectomy Lovastatin on Prostate CancerTerminatedNCT01478828Not applicableResults posted
• Sipuleucel-T Manufacturing Demonstration StudyCompletedNCT01477749Phase 2Results posted
• Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01468532Phase 1/2Results posted
• Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapyTerminatedNCT01450683Phase 2Results posted
• Dendritic Cell Vaccination and Docetaxel for Patients With Prostate CancerCompletedNCT01446731Phase 2Results posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• The Effects of Lycopene on High Risk Prostatic TissueCompletedNCT01443026Phase 2Results posted
• Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsCompletedNCT01434342Early Phase 1Results posted
• Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT01434290Phase 2Results posted
• Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryCompletedNCT01433913Phase 2Results posted
• Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerCompletedNCT01431391Phase 2Results posted
• Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001CompletedNCT01429064Phase 2Results posted
• Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to BoneTerminatedNCT01428219Phase 2Results posted
• A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01424930Phase 2Results posted
• Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer TherapyCompletedNCT01422850Phase 1Results posted
• Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate CancerTerminatedNCT01420965Phase 2Results posted
• GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate CancerTerminatedNCT01420861Phase 2Results posted
• Open-Label Access Protocol of Denosumab for Subjects With Advanced CancerCompletedNCT01419717Phase 3Results posted
• Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerCompletedNCT01415960Phase 3Results posted
• MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS TrialActive, not recruitingNCT01411345Not applicableResults posted
• Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT TrialCompletedNCT01411332Not applicableResults posted
• MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate CancerCompletedNCT01411319Not applicableResults posted
• Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate CancerCompletedNCT01393730Phase 2Results posted
• Phase II, Dose Finding Study of GTx-758TerminatedNCT01393119Phase 2Results posted
• Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational StudyCompletedNCT01386684Results posted
• BKM120 in Metastatic Castration-resistant Prostate CancerTerminatedNCT01385293Phase 2Results posted
• Axitinib Before Surgery in Treating Patients With High-Risk Prostate CancerCompletedNCT01385059Phase 2Results posted
• MR Image Guided Therapy in Prostate CancerCompletedNCT01377753Phase 2Results posted
• Ipilimumab + Androgen Depravation Therapy in Prostate CancerTerminatedNCT01377389Phase 2Results posted
• Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate CancerTerminatedNCT01374087Phase 2Results posted
• Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNCT01368588Phase 3Results posted
• Improving Urinary Continence and Quality of Life in Prostate Cancer PatientsCompletedNCT01365182Not applicableResults posted
• EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerCompletedNCT01360840Phase 2Results posted
• Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate CancerCompletedNCT01357512Not applicableResults posted
• Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate CancerTerminatedNCT01354951Phase 2Results posted
• Stereotactic Body Radiotherapy for Prostate CancerCompletedNCT01352598Not applicableResults posted
• Cabozantinib (XL184) in Men With Castrate-Resistant Prostate CancerCompletedNCT01347788Phase 1Results posted
• Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerActive, not recruitingNCT01342367Not applicableResults posted
• Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate CancerCompletedNCT01341652Phase 2Results posted
• Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate CancerCompletedNCT01338792Phase 2Results posted

← Prostatic Neoplasms overview